Hepatic Adenomata and Androgen Treatment
Authors: D. CARRASCO
Journal: Annals of Internal Medicine (1984)

Letters and Corrections1 February 1984Hepatic Adenomata and Androgen TreatmentD. CARRASCO, M.D., L. PALLARDO, M.D., M. PRIETO, M.D., J.L. MOLL, M.D., J.M. CRUZ, M.D., J. BERENGUER, M.D.D. CARRASCO, M.D.Search for more papers by this author, L. PALLARDO, M.D.Search for more papers by this author, M. PRIETO, M.D.Search for more papers by this author, J.L. MOLL, M.D.Search for more papers by this author, J.M. CRUZ, M.D.Search for more papers by this author, J. BERENGUER, M.D.Search for more papers by this authorAuthor, Article, and Disclosure Informationhttps://doi.org/10.7326/0003-4819-100-2-316_1 SectionsAboutPDF ToolsAdd to favoritesDownload CitationsTrack CitationsPermissions ShareFacebookTwitterLinkedInRedditEmail ExcerptTo the editor: Androgenic-anabolic steroids have been implicated in the genesis of primary liver tumours. Benign hepatic adenomas are rare and, to our knowledge, no previous case associated with long-term treatment with a non-17-alpha alkylated derivative has been described. We report hepatic adenomata in a renal transplant patient who had previously received androgenic treatment for 12 years. Careful questioning showed that the patient had never received a 17-alpha alkylated compound.A 32-year-old man with Alport's syndrome, on chronic hemodialysis since March 1973, received a cadaveric renal allograft in June 1983. Treatment was started in February 1971, with intramuscular nandrolone phenpropionate,...References1. Liver tumours and steroid hormones [Editorial]. Lancet. 1973;2:1481. MedlineGoogle Scholar2. ANTHONY P. Hepatoma associated with androgenic steroids. Lancet. 1975;1:685-6. CrossrefMedlineGoogle Scholar3. BAGHERIBOYER SJ. Peliosis hepatis associated with androgenic-anabolic steroid therapy: a severe form of hepatic injury. Ann Intern Med. 1974;81:610-8. LinkGoogle Scholar4. FALKTHOMASPOPPERISHAK HLHK. Hepatic angiosarcoma associated with androgenic-anabolic steroids. Lancet. 1979;2:1120-3. CrossrefMedlineGoogle Scholar This content is PDF only. To continue reading please click on the PDF icon. Author, Article, and Disclosure InformationAffiliations: Department of Internal Medicine Ciudad Sanitaria de la Seguridad Social La Fe Valencia-9 Spain PreviousarticleNextarticle Advertisement FiguresReferencesRelatedDetails Metrics Cited ByLiver cell adenoma showing sequential alteration of radiological findings suggestive of well-differentiated hepatocellular carcinomaAndrogens and liver tumors: Fanconi's anemia and non-Fanconi's conditionsClinical Use of Androgenic Steroids at a Major Medical Center: Who Prescribes Androgens and How Well Do They Do It?Effects of oral testosterone undecanoate on growth, body composition, strength and energy expenditure of adolescent boysAnabolic steroid abuse and toxicologyLiver pathology associated with the use of anabolic-androgenic steroidsSafety aspects of androgen therapyAdverse Effects of Anabolic SteroidsLiver structure and function during long-term treatment with cyproterone acetateA Non-C17-Alkylated Steroid and Long-term CholestasisVICENTE GARRIGUES GIL, M.D., JOAQUIN BERENGUER LAPUERTA, M.D., JULIO PONCE GARCIA, M.D., MIGUEL RAYON MARTIN, M.D. 1 February 1984Volume 100, Issue 2Page: 316-316KeywordsAdenomasAndrogensLiverRenal transplantationSteroids Issue Published: 1 February 1984 PDF DownloadLoading ...